Lunch Session Sponsored by Novo Nordisk

12:30-14:00   Tuesday, 25 April, 2017
Lunch Session Sponsored by Novo Nordisk - Hall J - Tiberias
Reducing the Risk for Cardiovascular Disease
Chair: Dr. Eldor Roy
 
 Time TopicSpeaker
12:45-13:10Diabetes and CV Disease: What is the Role of GLP-1 Receptor Agonist?Dr. Subodh-verma, University of Toronto, Canada
13:10- 13:35Approach to Management and Real- World Cases of Diabetics with CVDDr. Eldor Roy, Tel- Aviv Sourasky Medical Center, Israel
13:35-13:45Q & A 


To Register Click Here